array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(21) "Elevance Health, Inc."
["slug"]=>
string(19) "410d3-us-anthem-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/450d7e13-9f07-44cd-ac18-ed35846aceac"
["description"]=>
string(580) "Fueled by our bold purpose to improve the health of humanity, we are transforming from a traditional health benefits organization into a lifetime trusted health partner.
Our nearly 100,000 associates serve more than 118 million people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health.
We believe that improving health for everyone is possible. It begins by redefining health, reimagining the health system, and strengthening our communities."
["address_street"]=>
string(16) "220 Virginia Ave"
["address_place"]=>
string(12) "Indianapolis"
["address_region"]=>
string(7) "Indiana"
["founding_date"]=>
string(10) "1944-02-28"
["website_domain"]=>
string(18) "elevancehealth.com"
["website_url"]=>
string(30) "https://www.elevancehealth.com"
["industry_codes"]=>
array(2) {
[0]=>
string(29) "Accident and Health Insurance"
[1]=>
string(34) "Hospital and Medical Service Plans"
}
["employee_count"]=>
int(98200)
["article_count"]=>
int(548)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(57) "Elevance Health Inc, ordinary shares - quotes - Finmarket"
["snippet_en"]=>
string(45) "Elevance Health Inc, ordinary shares - quotes"
["url"]=>
string(67) "https://www.finmarket.ru/database/fintool/TotalQuotes.asp?id=127679"
["image_url"]=>
NULL
["source"]=>
string(12) "finmarket.ru"
["publication_date"]=>
string(10) "2024-02-15"
["categories"]=>
array(3) {
[0]=>
string(16) "Share Repurchase"
[1]=>
string(12) "Stock Market"
[2]=>
string(14) "Issuing Shares"
}
}
[1]=>
array(7) {
["title_en"]=>
string(54) "Elevance Health shares with price losses (€423.6894)"
["snippet_en"]=>
string(130) "In US securities trading, Elevance Health shares are currently in the red. Most recently, investors paid $460.33 for the security."
["url"]=>
string(88) "https://www.ariva.de/news/elevance-health-aktie-mit-kursverlusten-423-6894-euro-11110564"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/afba4187-6ab7-4a38-ba8a-4e1bfc0ab97d"
["source"]=>
string(8) "ariva.de"
["publication_date"]=>
string(10) "2024-01-18"
["categories"]=>
array(8) {
[0]=>
string(12) "Stock Market"
[1]=>
string(18) "General Investment"
[2]=>
string(14) "Issuing Shares"
[3]=>
string(21) "Competitive Behaviour"
[4]=>
string(9) "Investors"
[5]=>
string(15) "Market Movement"
[6]=>
string(16) "Share Repurchase"
[7]=>
string(24) "Quarterly/Annual Figures"
}
}
[2]=>
array(7) {
["title_en"]=>
string(54) "Elevance Health shares with price losses (€438.3762)"
["snippet_en"]=>
string(127) "In US securities trading, Elevance Health shares are currently in the red. Most recently, investors paid $480.00 for the stock."
["url"]=>
string(88) "https://www.ariva.de/news/elevance-health-aktie-mit-kursverlusten-438-3762-euro-11103583"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b3292131-fb8a-4019-badb-386cef208ce0"
["source"]=>
string(8) "ariva.de"
["publication_date"]=>
string(10) "2024-01-05"
["categories"]=>
array(9) {
[0]=>
string(12) "Stock Market"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(18) "General Investment"
[3]=>
string(14) "Issuing Shares"
[4]=>
string(21) "Competitive Behaviour"
[5]=>
string(9) "Investors"
[6]=>
string(15) "Market Movement"
[7]=>
string(16) "Share Repurchase"
[8]=>
string(24) "Quarterly/Annual Figures"
}
}
[3]=>
array(7) {
["title_en"]=>
string(59) "Elevance Health, Inc. (NYSE:ELV) Shares Purchased by Ossiam"
["snippet_en"]=>
string(190) "Ossiam increased its position in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 146.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC."
["url"]=>
string(98) "http://www.defenseworld.net/2023/09/10/elevance-health-inc-nyseelv-shares-purchased-by-ossiam.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/64b7bdff-6e7d-4e92-8429-ab91a9761ffb"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-09-10"
["categories"]=>
array(4) {
[0]=>
string(11) "Regulations"
[1]=>
string(18) "General Investment"
[2]=>
string(12) "Stock Market"
[3]=>
string(14) "Issuing Shares"
}
}
[4]=>
array(7) {
["title_en"]=>
string(70) "Possible Bearish Signals With Elevance Health Insiders Disposing Stock"
["snippet_en"]=>
string(120) "The fact that multiple Elevance Health, Inc. ( NYSE:ELV ) insiders offloaded a considerable amount of shares over the..."
["url"]=>
string(86) "https://finance.yahoo.com/news/possible-bearish-signals-elevance-health-110056600.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/79e9faf1-5ad2-414e-8995-1fa99875fa33"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-08-14"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(14) "Issuing Shares"
}
}
[5]=>
array(7) {
["title_en"]=>
string(65) "Elevance Health stock surges on earnings beat, full-year forecast"
["snippet_en"]=>
string(223) "Shares of Elevance Health jumped after topping its second-quarter earnings expectations and issuing a strong full-year outlook. Yahoo Finance Live take a look into the stock action surrounding the health insurance provider."
["url"]=>
string(78) "https://sg.news.yahoo.com/elevance-health-stock-surges-earnings-141635617.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/aee9b968-aef4-48d9-869b-3df0f9b4c60c"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-07-19"
["categories"]=>
array(5) {
[0]=>
string(12) "Stock Market"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(14) "Issuing Shares"
[3]=>
string(24) "Quarterly/Annual Figures"
[4]=>
string(31) "Financial Update/Profit Warning"
}
}
[6]=>
array(7) {
["title_en"]=>
string(78) "369 Shares in Elevance Health, Inc. (NYSE:ELV) Bought by Lindbrook Capital LLC"
["snippet_en"]=>
string(270) "Lindbrook Capital LLC bought a new position in shares of Elevance Health, Inc. (NYSE:ELV – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 369 shares of the company’s stock, valued at approximately $189,000."
["url"]=>
string(117) "http://www.defenseworld.net/2023/04/06/369-shares-in-elevance-health-inc-nyseelv-bought-by-lindbrook-capital-llc.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4786b2bf-8631-4847-9fd6-a593e821e6cb"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-04-06"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(14) "Issuing Shares"
}
}
[7]=>
array(7) {
["title_en"]=>
string(74) "Elevance Health (NYSE:ELV) Coverage Initiated by Analysts at StockNews.com"
["snippet_en"]=>
string(276) "Equities research analysts at StockNews.com started coverage on shares of Elevance Health (NYSE:ELV – Get Rating) in a research note issued to investors on Thursday. The brokerage set a “strong-buy” rating on the stock. ELV has been the subject of several other reports."
["url"]=>
string(115) "http://www.defenseworld.net/2023/03/16/elevance-health-nyseelv-coverage-initiated-by-analysts-at-stocknews-com.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4ea67f95-c99f-4af6-ac23-ae7438da009a"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-03-16"
["categories"]=>
array(4) {
[0]=>
string(13) "Credit Rating"
[1]=>
string(12) "Stock Market"
[2]=>
string(10) "Litigation"
[3]=>
string(14) "Issuing Shares"
}
}
[8]=>
array(7) {
["title_en"]=>
string(59) "Chart of the Day: Here's a Stock Looking for Some Elevation"
["snippet_en"]=>
string(52) "This might be an excellent spot to stockpile shares."
["url"]=>
string(106) "https://aap.thestreet.com/story/16118333/1/chart-of-the-day-here-s-a-stock-looking-for-some-elevation.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/909156e0-7274-4e7f-8b60-a653c733658d"
["source"]=>
string(13) "thestreet.com"
["publication_date"]=>
string(10) "2023-03-14"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(14) "Issuing Shares"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(96)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(61)
}
[2]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(55)
}
[3]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(30)
}
[4]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(28)
}
[5]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(23)
}
[6]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(21)
}
[8]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(20)
}
[9]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(15)
}
[10]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[11]=>
array(2) {
["name"]=>
string(22) "Purchasing contracting"
["count"]=>
int(13)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(10)
}
[15]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(10)
}
[16]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(10)
}
[17]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[21]=>
array(2) {
["name"]=>
string(11) "Name Change"
["count"]=>
int(8)
}
[22]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(8)
}
[23]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(7)
}
[26]=>
array(2) {
["name"]=>
string(19) "Under Investigation"
["count"]=>
int(7)
}
[27]=>
array(2) {
["name"]=>
string(7) "Opening"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(6)
}
[29]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(6)
}
}
}
410d3-us-anthem-inc
Elevance Health, Inc.
Location
Indiana
Founded
1944-02-28
Website
https://www.elevancehealth.com
Articles
548 Articles
Category
Accident and Health Insurance
Hospital and Medical Service Plans
Description
Fueled by our bold purpose to improve the health of humanity, we are transforming from a traditional health benefits organization into a lifetime trusted health partner.
Our nearly 100,000 associates serve more than 118 million people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health.
We believe that improving health for everyone is possible. It begins by redefining health, reimagining the health system, and strengthening our communities.
Ossiam increased its position in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 146.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC.
Shares of Elevance Health jumped after topping its second-quarter earnings expectations and issuing a strong full-year outlook. Yahoo Finance Live take a look into the stock action surrounding the health insurance provider.
Lindbrook Capital LLC bought a new position in shares of Elevance Health, Inc. (NYSE:ELV – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 369 shares of the company’s stock, valued at approximately $189,000.
Equities research analysts at StockNews.com started coverage on shares of Elevance Health (NYSE:ELV – Get Rating) in a research note issued to investors on Thursday. The brokerage set a “strong-buy” rating on the stock. ELV has been the subject of several other reports.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
